Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Plumbagin suppresses non-small cell lung cancer progression through downregulating ARF1 and by elevating CD8+ T cells
Zebo Jiang, Cong Xu, Wenjun Wang, et al.
Pharmacological Research (2021) Vol. 169, pp. 105656-105656
Closed Access | Times Cited: 21

Showing 21 citing articles:

Unlocking the potential of 1,4-naphthoquinones: A comprehensive review of their anticancer properties
Eduardo Angulo-Elizari, Andreina Henriquez-Figuereo, Cristina Morán-Serradilla, et al.
European Journal of Medicinal Chemistry (2024) Vol. 268, pp. 116249-116249
Open Access | Times Cited: 9
Synergistic Anticancer Activity of Plumbagin and Xanthohumol Combination on Pancreatic Cancer Models
Ranjith Palanisamy, Nimnaka Indrajith Kahingalage, David Archibald, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2340-2340
Open Access | Times Cited: 7
A review of natural products targeting tumor immune microenvironments for the treatment of lung cancer
Pengyu Yao, Liang Su, Zhenying Liu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Tetrandrine activates STING/TBK1/IRF3 pathway to potentiate anti-PD-1 immunotherapy efficacy in non-small cell lung cancer
Yan Zhi Tan, Qiancheng Zhu, Meilin Yang, et al.
Pharmacological Research (2024) Vol. 207, pp. 107314-107314
Open Access | Times Cited: 5
Prominent Naturally Derived Oxidative-Stress-Targeting Drugs and Their Applications in Cancer Treatment
Eunsun Lee, Dongki Yang, Jeong Hee Hong
Antioxidants (2025) Vol. 14, Iss. 1, pp. 49-49
Open Access
Investigating the interaction between calcium signaling and ferroptosis for novel cancer treatment
Haohao Yan, Ying‐Chuang Zhang, Yuqing Niu, et al.
Phytomedicine (2025) Vol. 137, pp. 156377-156377
Closed Access
Rutecarpine Suppresses Non‐Small Cell Lung Cancer Progression Through Activating the STING Pathway and Elevating CD8+ T Cells
Zebo Jiang, Qiang He, Liping Kang, et al.
Chemical Biology & Drug Design (2025) Vol. 105, Iss. 2
Closed Access
Modulation of inflammation by phytochemicals to enhance efficacy and reduce toxicity of cancer chemotherapy
Taha Koray Şahin, Birdal Bilir, Ömer Küçük
Critical Reviews in Food Science and Nutrition (2021) Vol. 63, Iss. 15, pp. 2494-2508
Closed Access | Times Cited: 21
Modulatory Role of Phytochemicals/Natural Products in Cancer Immunotherapy
Yadu Vijayan, Jaskirat Singh Sandhu, Kuzhuvelil B. Harikumar
Current Medicinal Chemistry (2024) Vol. 31, Iss. 32, pp. 5165-5177
Closed Access | Times Cited: 2
Plumbagin has an inhibitory effect on the growth of TSCC PDX model and it enhances the anticancer efficacy of cisplatin
Yuqi Xin, Qingkun Jiang, Chenshu Liu, et al.
Aging (2023) Vol. 15, Iss. 21, pp. 12225-12250
Open Access | Times Cited: 5
Upgrade of chrysomycin A as a novel topoisomerase II inhibitor to curb KRAS-mutant lung adenocarcinoma progression
Junmin Zhang, Pei Liu, Jianwei Chen, et al.
Pharmacological Research (2022) Vol. 187, pp. 106565-106565
Open Access | Times Cited: 9
Plumbagin induces G2/M arrest and apoptosis and ferroptosis via ROS/p38 MAPK pathway in human osteosarcoma cells
Jintang Li, Hang Gao, Ping Wang, et al.
Alexandria Engineering Journal (2024) Vol. 103, pp. 222-236
Open Access | Times Cited: 1
Pharmacological Features and Therapeutic Implications of Plumbagin in Cancer and Metabolic Disorders: A Narrative Review
Bhoomika Sharma, Chitra Dhiman, Gulam Mustafa Hasan, et al.
Nutrients (2024) Vol. 16, Iss. 17, pp. 3033-3033
Open Access | Times Cited: 1
Exploring natural resources: Plumbagin as a potent anticancer agent
Iftikhar Ahmad, Shams Tabrez
South African Journal of Botany (2024) Vol. 174, pp. 167-179
Closed Access | Times Cited: 1
Endoplasmic Reticulum Stress-Related Signature for Predicting Prognosis and Immune Features in Hepatocellular Carcinoma
Genhao Zhang, Jianping Sun
Journal of Immunology Research (2022) Vol. 2022, pp. 1-18
Open Access | Times Cited: 7
Unravelling the potent anti-oxidant and anti-inflammatory actions of plumbagin: A review of preclinical discoveries
Aanchal Verma, Ahsas Goyal
Pharmacological Research - Modern Chinese Medicine (2023) Vol. 10, pp. 100351-100351
Open Access | Times Cited: 2
Synthesis and Characterization of Plumbagin S-Allyl Cysteine Ester: Determination of Anticancer Activity In Silico and In Vitro
Sudha Vijayan, Chitra Loganathan, Penislusshiyan Sakayanathan, et al.
Applied Biochemistry and Biotechnology (2022) Vol. 194, Iss. 12, pp. 5827-5847
Closed Access | Times Cited: 4
Host protein ARF1 is a proviral factor for SARS-CoV-2 and a candidate broad-spectrum therapeutic target
Yun‐Jia Ning, Cunhuan Zhang, Yuan‐Qin Min, et al.
Research Square (Research Square) (2024)
Open Access
Exploring the potential biological significance of KDELR family genes in lung adenocarcinoma
Peitong Li, Pengfei Cui, Qing Yue, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
The phytochemical plumbagin: mechanism behind its “pleiotropic” nature and potential as an anticancer treatment
Shikshya Swarupa Panda, Bijesh K. Biswal
Archives of Toxicology (2024)
Closed Access
Review on effects and mechanisms of plant-derived natural products against breast cancer bone metastasis
Xiaolei Zhang, Jinxin Miao, Yagang Song, et al.
Heliyon (2024) Vol. 10, Iss. 18, pp. e37894-e37894
Open Access
Lycorine Suppresses Non‐Small‐Cell Lung Cancer Progression Through Activating STING Pathway and Stimulating an Antitumor Immune Response
Zebo Jiang, Cong Xu, Pan Xu, et al.
Chemical Biology & Drug Design (2024) Vol. 104, Iss. 6
Closed Access
Page 1

Scroll to top